Pernetrexed second-line treatment in malignant pleural mesothelioma following platinum-based first-line

被引：2
|
作者：
Sorensen, J. B.
Sundstrom, S.
Perell, K.
Thielsen, A.
机构：
[1] Natl Univ Hosp, Finsen Ctr, Copenhagen, Denmark
[2] St Olav Hosp, Trondheim, Norway
来源：
LUNG CANCER | 2006年 / 54卷
关键词：
D O I：
10.1016/S0169-5002(07)70268-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
192
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [21] A retrospective analysis of second-line chemotherapy for malignant pleural mesothelioma (MPM)
    La Verde, N. M.
    Bramati, A.
    Cinquini, M.
    Tiseo, M.
    Collova, E.
    Michetti, A.
    Lo Dico, M.
    Foliador, A.
    Garassino, M. C.
    Zucaii, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] A RETROSPECTIVE ANALYSIS OF SECOND-LINE CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Bramati, A.
    Moretti, A.
    Garassino, M. C.
    Califano, R.
    Farina, G.
    Lo Dico, M.
    Cinquini, M.
    Michetti, G. N.
    Tiseo, M.
    Zucali, P. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S103 - S103
  • [23] Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy
    Toyokawa, Gouji
    Takenoyama, Mitsuhiro
    Hirai, Fumihiko
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Morodomi, Yosuke
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Shimokawa, Mototsugu
    Seto, Takashi
    Ichinose, Yukito
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 601 - 606
  • [24] Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy
    Gouji Toyokawa
    Mitsuhiro Takenoyama
    Fumihiko Hirai
    Ryo Toyozawa
    Eiko Inamasu
    Miyako Kojo
    Yosuke Morodomi
    Yoshimasa Shiraishi
    Tomoyoshi Takenaka
    Masafumi Yamaguchi
    Mototsugu Shimokawa
    Takashi Seto
    Yukito Ichinose
    International Journal of Clinical Oncology, 2014, 19 : 601 - 606
  • [25] First-line vs second-line antibiotics for treatment of sinusitis
    Anon, JB
    Jacobs, MR
    Poole, MD
    Singer, ME
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11): : 1395 - 1395
  • [26] Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?
    Apostolidis, Apostolos
    CURRENT DRUG TARGETS, 2015, 16 (11) : 1187 - 1197
  • [27] Treating bladder cancer: first-line, second-line, platinum-unfit
    De Santis, M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S3 - S4
  • [28] Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really “Raising the Bar?”
    Vincenzo Di Noia
    Emanuele Vita
    Miriam Ferrara
    Antonia Strippoli
    Michele Basso
    Giovanni Schinzari
    Alessandra Cassano
    Emilio Bria
    Carlo Barone
    Ettore D’Argento
    Current Treatment Options in Oncology, 2019, 20
  • [29] Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey
    Zucali, P. A.
    Simonelli, M.
    Michetti, G.
    Tiseo, M.
    Ceresoli, G. L.
    Collova, E.
    Follador, A.
    Lo Dico, M.
    Moretti, A.
    De Vincenzo, F.
    Lorenzi, E.
    Perrino, M.
    Giordano, L.
    Farina, G.
    Santoro, A.
    Garassino, M.
    LUNG CANCER, 2012, 75 (03) : 360 - 367
  • [30] Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?"
    Di Noia, Vincenzo
    Vita, Emanuele
    Ferrara, Miriam
    Strippoli, Antonia
    Basso, Michele
    Schinzari, Giovanni
    Cassano, Alessandra
    Bria, Emilio
    Barone, Carlo
    D'Argento, Ettore
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (03)
12345